589 related articles for article (PubMed ID: 10627494)
21. The genetics of medically important fungi.
Whelan WL
Crit Rev Microbiol; 1987; 14(2):99-170. PubMed ID: 3549159
[TBL] [Abstract][Full Text] [Related]
22. Friend or foe: using systems biology to elucidate interactions between fungi and their hosts.
Rizzetto L; Cavalieri D
Trends Microbiol; 2011 Oct; 19(10):509-15. PubMed ID: 21871806
[TBL] [Abstract][Full Text] [Related]
23. Disruption of the phospholipase D gene attenuates the virulence of Aspergillus fumigatus.
Li X; Gao M; Han X; Tao S; Zheng D; Cheng Y; Yu R; Han G; Schmidt M; Han L
Infect Immun; 2012 Jan; 80(1):429-40. PubMed ID: 22083709
[TBL] [Abstract][Full Text] [Related]
24. Nitrogen regulation of virulence in clinically prevalent fungal pathogens.
Lee IR; Morrow CA; Fraser JA
FEMS Microbiol Lett; 2013 Aug; 345(2):77-84. PubMed ID: 23701678
[TBL] [Abstract][Full Text] [Related]
25. TOP2 gene is involved in the pathogenicity of Candida albicans.
Zheng H; Yu YS
Mol Cell Biochem; 2012 May; 364(1-2):45-52. PubMed ID: 22203422
[TBL] [Abstract][Full Text] [Related]
26. Cell wall proteome of pathogenic fungi.
Karkowska-Kuleta J; Kozik A
Acta Biochim Pol; 2015; 62(3):339-51. PubMed ID: 26192771
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans.
Kunze D; Melzer I; Bennett D; Sanglard D; MacCallum D; Nörskau J; Coleman DC; Odds FC; Schäfer W; Hube B
Microbiology (Reading); 2005 Oct; 151(Pt 10):3381-3394. PubMed ID: 16207920
[TBL] [Abstract][Full Text] [Related]
28. Iron Metabolism, Pseudohypha Production, and Biofilm Formation through a Multicopper Oxidase in the Human-Pathogenic Fungus Candida parapsilosis.
Chakraborty T; Tóth Z; Tóth R; Vágvölgyi C; Gácser A
mSphere; 2020 May; 5(3):. PubMed ID: 32404511
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species Comparison.
Pais P; Costa C; Cavalheiro M; Romão D; Teixeira MC
Front Cell Infect Microbiol; 2016; 6():131. PubMed ID: 27812511
[TBL] [Abstract][Full Text] [Related]
30. Tobacco Hornworm (
Lyons N; Softley I; Balfour A; Williamson C; O'Brien HE; Shetty AC; Bruno VM; Diezmann S
Virulence; 2020 Dec; 11(1):1075-1089. PubMed ID: 32842847
[TBL] [Abstract][Full Text] [Related]
31. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi.
Walsh TJ; Francesconi A; Kasai M; Chanock SJ
J Clin Microbiol; 1995 Dec; 33(12):3216-20. PubMed ID: 8586705
[TBL] [Abstract][Full Text] [Related]
32. Pre-exposure to
Huang XW; Xu MN; Zheng HX; Wang ML; Li L; Zeng K; Li DD
Virulence; 2020 Dec; 11(1):1674-1684. PubMed ID: 33200667
[TBL] [Abstract][Full Text] [Related]
33. Housekeeping enzymes as virulence factors for pathogens.
Pancholi V; Chhatwal GS
Int J Med Microbiol; 2003 Dec; 293(6):391-401. PubMed ID: 14760970
[TBL] [Abstract][Full Text] [Related]
34. Comparison of enzymatic activities in different Candida species isolated from women with vulvovaginitis.
Fatahinia M; Halvaeezadeh M; Rezaei-Matehkolaei A
J Mycol Med; 2017 Jun; 27(2):188-194. PubMed ID: 28236530
[TBL] [Abstract][Full Text] [Related]
35. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
36. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
[TBL] [Abstract][Full Text] [Related]
37. Role of phospholipases in fungal fitness, pathogenicity, and drug development - lessons from cryptococcus neoformans.
Djordjevic JT
Front Microbiol; 2010; 1():125. PubMed ID: 21687772
[TBL] [Abstract][Full Text] [Related]
38. Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.
Thammahong A; Puttikamonkul S; Perfect JR; Brennan RG; Cramer RA
Microbiol Mol Biol Rev; 2017 Jun; 81(2):. PubMed ID: 28298477
[TBL] [Abstract][Full Text] [Related]
39. Highlights in pathogenic fungal biofilms.
Sardi Jde C; Pitangui Nde S; Rodríguez-Arellanes G; Taylor ML; Fusco-Almeida AM; Mendes-Giannini MJ
Rev Iberoam Micol; 2014; 31(1):22-9. PubMed ID: 24252828
[TBL] [Abstract][Full Text] [Related]
40. Bacterial Sphingomyelinases and Phospholipases as Virulence Factors.
Flores-Díaz M; Monturiol-Gross L; Naylor C; Alape-Girón A; Flieger A
Microbiol Mol Biol Rev; 2016 Sep; 80(3):597-628. PubMed ID: 27307578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
